HOME >> MEDICINE >> NEWS
AACR supports the nomination of Andrew von Eschenbach as the commissioner of the FDA

PHILADELPHIA The American Association for Cancer Research, the world's oldest and largest organization dedicated to cancer research, enthusiastically supports the nomination of Andrew von Eschenbach as new commissioner of the U.S. Food and Drug Administration.

"Dr. von Eschenbach brings enormous medical and administrative expertise and experience to this post," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "This background will be vitally important in his new challenging role of FDA commissioner."

In the cancer community, Dr. von Eschenbach, 64, is a well-recognized urologic surgeon who formerly directed the Genitourinary Cancer Center and the Prostate Cancer Research Program at The University of Texas M. D. Anderson Cancer Center. Dr. von Eschenbach spent a quarter of a century there, moving from faculty member to department chair to executive vice president and chief academic officer.

Subsequently, Dr. von Eschenbach was named Director of the National Cancer Institute, the 12th person to assume this responsibility in the NCI's 67-year old history. During his tenure, he worked to strengthen collaborations between the NCI and the FDA, and to bring laboratory breakthroughs to the clinic as quickly as possible, maximizing patient benefits and minimizing risks. As part of this collaboration, the NCI and FDA through a joint agency task force agreed to share knowledge and resources to facilitate the development of new cancer drugs and speed their delivery to patients.

"Dr. von Eschenbach also has a special appreciation for translational cancer research, the process that bridges basic research with clinical research, with the goal of bringing new discoveries to the cancer patient," said Peter Jones, Ph.D., D.Sc., AACR president and director of the University of Southern California/Norris Comprehensive Cancer Center and Distinguished Professor of Urology and Biochemistry & Molecular Biolog
'"/>

Contact: Warren R. Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
15-Mar-2006


Page: 1 2

Related medicine news :

1. Michigan-CDC study supports value of social restrictions during influenza pandemics
2. ACP supports improved access to information on relative strengths and weaknesses
3. Study supports activity of GEMZAR in the treatment of early-stage breast cancer
4. New research supports early testing for prostate cancer
5. ACP enthusiastically supports introduction of Bipartisan Health CARE Act
6. ACP supports new bill to promote adoption of health information technology
7. New data supports a non-invasive approach to routine prenatal genetic testing
8. Existing research supports metabolic syndrome link to cardiovascular disease
9. Medscape review supports effectiveness and safety of new non-drug blood pressure treatment
10. New study supports major change in diet treatment for diabetes
11. Wild vs. lab rodent comparison supports hygiene hypothesis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2019)... ... June 20, 2019 , ... SightMD (or the ... Founders, announced a strategic partnership with Northern Westchester Ophthalmology, P.C. (“NWO”) and its ... in New York, adding the Company’s first location in Westchester County to SightMD’s ...
(Date:6/19/2019)... ... 19, 2019 , ... The number of public health departments ... of performance continues to climb. Today, the Public Health Accreditation Board ... public health departments. With this week's accreditation decisions, tens of thousands more people ...
(Date:6/19/2019)... ... June 19, 2019 , ... The ... Congress (IRC) in Marseille, France. The conference is widely seen as the ... muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, industry representatives and patient advocates are ...
(Date:6/18/2019)... ... June 18, 2019 , ... EMulate Therapeutics, Inc. ... serious diseases, announced it has received notice that the US Food and Drug ... (HDE) for the Hælo Pediatric system. The FDA granted the Humanitarian Use ...
(Date:6/18/2019)... ST. LOUIS (PRWEB) , ... June 18, 2019 ... ... cost, quality and clinical outcomes, today announced Steve Einig has joined the organization ... will lead strategy and corporate initiatives around market engagement, marketing, strategic events and ...
Breaking Medicine News(10 mins):
(Date:6/19/2019)... RESEDA, California (PRWEB) , ... June 19, 2019 , ... ... women living together at the Los Angeles Jewish Home (LAJH). Known as a destination ... For many seniors, including Edith Frankie, Linda Frankes, and Mildred Moccio, it is also ...
(Date:6/19/2019)... ... June 19, 2019 , ... Center for Vein Restoration (CVR) CEO and ... Top CEOs in 2019 . Glassdoor , one of the world’s largest ... world-class leaders that employees love working for throughout North America and parts of Europe. ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... Senior citizens ... age and this vitality can be a double-edged sword leading seniors to put off ... living specialists and Certified Senior Advisors at Elder Placement Professionals have some suggestions ...
Breaking Medicine Technology:
Cached News: